Gates, Novo Nordisk And Wellcome Commit $300 Million To Climate Change, Infectious Diseases And Nutrition

  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 34 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 59%

Gates News

Novo Nordisk,Gates Foundation,Bill Gates

I am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.

The Bill & Melinda Gates Foundation, Wellcome Trust and Novo Nordisk Foundation joined forces on Monday to tackle some of the world’s most pressing health problems, an endeavor that pulls together three of philanthropy’s biggest players to tap developments in science and technology at a time when funding and attention for global health among governments is faltering.

The project will first fund research and solutions that address three major global health challenges, all of which disproportionately impact the world’s poorest people: the health impacts of climate change; infectious disease and antimicrobial resistance; and better understanding the interplay between nutrition, immunity, disease and development.

“By pooling the vast experience and unique expertise of each organization… we can make advances that wouldn’t otherwise be possible,” said Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen, adding that he’s “particularly excited about the chance to break down barriers between often isolated areas of work.”

Novo Nordisk Gates Foundation Bill Gates Wellcome Global Health Philanthropy

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 318. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novo Nordisk trims price for blockbuster obesity drug as competition heats upNovo Nordisk raised its 2024 outlook on Thursday as the Danish drugmaker races to boost output of its Wegovy weight-loss treatment, while competition from rival Eli Lilly forced the company to cut prices of the drug, knocking its shares.
Source: Reuters - 🏆 2. / 97 Read more »

Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortagesNovo Nordisk's Negelle Morris spoke exclusively with ABC News.
Source: ABC - 🏆 471. / 51 Read more »

Novo Nordisk executive responds to criticisms of Ozempic cost, availabilityNegelle Morris, Novo Nordisk's senior vice president and head of U.S. cardiometabolic sales, spoke exclusively with ABC News.
Source: 6abc - 🏆 250. / 63 Read more »

European markets higher; French banks gain on profit beats as Novo Nordisk slidesEuropean stock markets traded in the green on Friday, rounding off a broadly negative week dominated by corporate earnings.
Source: CNBC - 🏆 12. / 72 Read more »

Novo Nordisk, Eli Lilly drop on Amgen competition concernsNovo Nordisk, Eli Lilly drop on Amgen competition concerns
Source: Investingcom - 🏆 450. / 53 Read more »

Wegovy maker Novo Nordisk down 4%, heads for worst day since OctoberAnalysts pored over the details in its first-quarter results and monitored a potential rival weight loss treatment.
Source: CNBC - 🏆 12. / 72 Read more »